Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
10 participants
OBSERVATIONAL
2009-06-30
2012-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators predict that there will be changes in A) trunk muscle electromyographic patterns and in temporo-spatial gait patterns following osteopathic treatment.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Osteopathic Health Outcomes in Chronic Low Back Pain (OSTEOPATHIC) Trial
NCT00315120
A Pilot MRI Study of Osteopathic Manipulative Treatment of Acute Low Back Pain
NCT00562562
Study of the Contribution of Osteopathic Treatment to Classic Medical Management in Patients With Chronic Low Back Pain
NCT03836248
How Osteopathic Treatment Affects the Leg and Foot in People With Low Back Pain
NCT07193212
Effects and Mechanisms of Specific Trunk Exercises in Low Back Pain
NCT01611792
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In a controlled trial which measured levels of cellular enzymes to monitor tissue damage during OMT, blood serum enzyme levels did not change as a result of manipulation. More important, EMG levels decreased. OMT did not damage tissue but changed motor neuron activity (Rowane, Horner, Warner, et al., 1989). Beckman, et al., (1991) observed a reduction in EMG activity following OMT in patients with low back pain and found increased skin blood flow as measured by laser doppler flow meter. Steiner et al. (1991), reveal reduction to muscle spasm as measured by EMG in patients with low back pain following OMT. A further study (Ellestad, et al., 1988) noted decreased EMG activity during motion in patients with chronic low back pain. Thus there is preliminary work providing support for reduced EMG activity following OMT within low back pain treatment groups. However there is a need for further research in this area.
We also want to determine the role of manual therapy (osteopathy) in the management of gait dysfunction in this patient population. Patients with LBP present with reduced gait speed, poor thoraco-pelvic coordination and increased erector spinae activity (Lamoth et al. 2002 and 2006), altered weight bearing (Ellen Lee et al., 2007) and reduced single leg stance balance in static conditions (Louto et al., 1998).
Reduced thoraco-pelvic coordination leads to muscular stabilizing effects, altered kinematics, trunk rigidity, and reduced walking velocity (Lamoth et al., 2002). Specific impairments of body structure and function can reduce gait speed in older adults (Kerrigan, Todd, Della Cruce, 1998). Osteopathic intervention targets movement impairments of body structure and should change gait speed in patients with chronic LBP. Mal-alignment contributes to pathology in the pelvis and lumbar spine which can lead to degenerative changes, instability and pain (Aebi, 2005; Gurney, 2002; Steinburg, Luger, Arbel, et al., 2003). The focus of osteopathy is to restore mobility and alignment throughout the whole kinetic chain (Kutchera and Kutchera, 1991; Seffinger, 2007).
Improvement in gait speed and joint motion is shown after mobilization exercises to the ankle and hip in the elderly (Christiansen, 2003). A kinetic relationship links the ankle and pelvis (Gurney, 2002; Khamis \& Yizhar, 2007; Pinto, Souza, Tede, et al., 2008). Cephalo-caudal (pelvis affects ankle), caudal-cephalo (ankle affects pelvis) and ipsilateral-contralateral (one leg affects the other via the pelvis) alignment and kinematic relationships occur when lower extremity joints are maintained in altered positions (Pinto, et al., 2008). Can movement dysfunction secondary to impaired mobility and mal-alignment contribute to pain and antalgic gait?
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Back Pain
Patients with chronic mechanical low back pain (Chronic low back pain is defined as having "pain between the lower ribs and gluteal folds, with minimal radiation to the thigh and never below the knee, present for a minimum of seven weeks")
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* able to walk without assistance and /or assistive devices at least 4.7 meters.
* have adequate hearing acuity to detect verbal instructions.
* have adequate visual acuity to walk safely in usual ambient lighting without holding onto objects.
* be able to speak and comprehend English,
* have sufficient cognitive ability to follow instructions, and to provide informed consent, as defined by a Mini Mental Status Examination score of greater than 23 out of 30, performed by the research coordinator.
Exclusion Criteria
* are active in a claim pertaining to a motor vehicle accident or work injury or under any litigation for their pain.
* have had previous osteopathic treatment in the last year.
* had more than one abdominal surgery, or spinal fracture, or structural deformity such as scoliosis or spondylolithesis (Hubley-Kozey, 2002)
* have severe cardiopulmonary disease as determined by a health questionnaire with symptoms such as shortness of breath or chest pain on mild exertion or at rest,
* history of severe neurological disorder that impairs balance and mobility eg stroke, Parkinson's disease, peripheral neuropathy
* have pain that leads to severe discomfort with minimal movement,
* have significant musculoskeletal impairment e.g. arthritis that leads to severe discomfort with walking that could lead to an abnormal gait,
* have cognitive compromise impairing ability to care for oneself, and ability to provide informed consent,
* have dizziness while standing,
* have a history of falls in previous month that might make it unsafe to participate in a gait study
19 Years
55 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mary Lynch
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mary Lynch
MD FRCPC
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mary Lynch, MD
Role: PRINCIPAL_INVESTIGATOR
Nova Scotia Health Authority
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CDHA Pain Management Unit
Halifax, Nova Scotia, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CDHA-RS/2009-366
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.